USANA Health Sciences Board of Directors Forms a Special Committee of Independent...

USANA Health Sciences Board of Directors Forms a Special Committee of Independent Directors to Review Take-Private Offer

Special Committee Retains Legal Advisor to Assist in its Review
SALT LAKE CITY--(Business Wire)--
USANA Health Sciences, Inc. (NASDAQ: USNA) today announced that
its Board of Directors have formed a Special Committee of independent
directors to evaluate an offer expected to be made by Gull Holdings,
Ltd. and others to acquire all of the outstanding shares of USANA
common stock not already owned by Gull Holdings and the other tender
offer participants at a cash purchase price of $26.00 per share. Gull
Holdings and others indicated their intent to make such an offer on a
Schedule TO filed with the Securities and Exchange Commission (SEC) on
May 13, 2008. No offer had been commenced as of the time of this press
release.

The Special Committee has retained Morrison & Foerster LLP as its
legal advisor to assist in its evaluation of the proposed offer. The
Special Committee is also in the process of identifying and retaining
a financial advisor to assist with its evaluation of the proposed
offer. Neither USANA nor the Special Committee plan to update the
market with any further comments relating to the proposed offer until
after the tender offer has been issued and the relevant evaluation has
been performed.

If a tender offer for USANA's common stock is commenced,
shareholders are urged to read USANA's solicitation/recommendation
statement on Schedule 14D-9, which would be filed with the SEC,
because it will contain important information. Shareholders can obtain
a free copy of the solicitation/recommendation statement and any
amendments to that statement, if and when available, and all other
filings by USANA with the SEC at www.sec.gov.

About USANA

USANA develops and manufactures high quality nutritional, personal
care, and weight management products that are sold directly to
Preferred Customers and Associates throughout the United States,
Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea,
Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom.
More information on USANA can be found at
http://www.usanahealthsciences.com.

Safe Harbor

This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act, including but not limited to statements
regarding the proposed tender offer and the Company's and the Special
Committee's intentions with respect to any such tender offer. Our
actual results could differ materially from those projected in these
forward-looking statements, which involve a number of risks and
uncertainties, including reliance upon our network of independent
Associates, the governmental regulation of our products, manufacturing
and marketing risks, adverse publicity risks, and risks associated
with our international expansion. The contents of this release should
be considered in conjunction with the risk factors, warnings, and
cautionary statements that are contained in our most recent filings
with the Securities and Exchange Commission.

USANA Health Sciences, Inc.
Riley Timmer, 801-954-7922 (Investor Relations)
investor.relations@us.usana.com
or
Edelman
Joe Poulos, 011-44-796-772-3291
Joseph.poulos@edelman.com

Copyright Business Wire 2008